Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE:MTEC, Frankfurt:3CM), a leading business technology company in the cannabis space, continues to develop a substantial set of educational modules surrounding the consumption of cannabis-infused food and beverages for its Cannvas.Me educational platform. Leveraging the Company’s Health and Innovation Advisory Board, Medical Advisory Board and Education Advisory Panel, made up of members from industry and government institutions, Cannvas.Me will deliver comprehensive and credible information on the potential benefits of cannabis-infused edibles.

“We see immense opportunity for Cannvas.Me to become a leader in education on the subject of cannabis-infused food and beverage for medicinal and adult-use cannabis users, particularly with the emergence of major brands partnering with cannabis producers to explore this space,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “International companies are rushing to cannabis to create trendy and innovative consumer products and there is little credible information available to the public on whether these products will be beneficial to their lifestyle, a gap we expect to fill with our educational platform Cannvas.Me.”


As The Company continues to grow, recently expanding its team to 19 members and actively growing its partnership base with national and international organizations, it intends to harness the expertise of its staff, who bring with them years of experience working with food and beverage clients across Canada, to further guide content creation centered around cannabis-infused food and beverage. Cannvas recently hired Daniel Davidzon, who brings with him a wealth of experience in the foodservice industry including having helped grow Aroma Espresso Bar Canada from 20 to 46 locations in a four-year span.

“I look forward to sharing my expertise in foodservice and hospitality and staying on top of industry trends with the Cannvas.Me Health and Innovation Advisory Board, Medical Advisory Board and Education Advisory Panel to enrich the content our platform offers our users,” said Daniel Davidzon, Marketing Manager, Cannvas MedTech Inc. “We intend to stay at the forefront of the food and beverage industry not only in regards to cannabis-infused edibles but overall food trends to ensure we deliver credible information, quality recipes and the latest insights into the use of cannabis in edible or drinkable form.”

Cannvas.Me is a scalable and comprehensive solution for the global medical cannabis community offering interactive tools and physician-backed content to audiences wishing to learn about healthcare through cannabis. Its Cannvas Culinary educational modules encourage users to browse recipes and expert advice on cannabis consumption from accomplished chefs and cannabis advocates, dispelling the stigma that edibles only comprise candy, chocolate, cookies, or other sugar-filled desserts by showcasing simple and nutritious alternatives. Cannvas recently named Cody Lindsay, a veteran of the Canadian military, chef, cannabis advocate, and owner of The Wellness Soldier, as the featured expert for culinary cannabis on its learning platform Cannvas.Me

About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

For additional information:
www.cannvasmedtech.com

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.

For further information: Media Inquiries: media@cannvasmedtech.com; Investor Relations, ir@cannvasmedtech.com, 1-800-489-0116

Click here to connect with Cannvas MedTech Inc. (CSE:MTEC, Frankfurt:3CM) for an Investor Presentation.

Source: www.newswire.ca

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less